CAN FITE BIOPHARMA LTD-ADR (CANF)
US13471N3008 - ADR
CAN FITE BIOPHARMA LTD-ADR
NYSEARCA:CANF (12/18/2024, 8:07:11 PM)
After market: 1.31 -0.02 (-1.5%)1.33
-0.09 (-6.34%)
Company Profile
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The firm co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Company Info
CAN FITE BIOPHARMA LTD-ADR
26 Ben Gurion Street
Ramat Gan 4951778
P: 97239241114
CEO: Pnina Fishman
Employees: 5
Website: https://www.canfite.com/
CANF News
12 days ago - ChartmillUnusual volume stocks in Friday's sessionLet's have a look at what is happening on the US markets on Friday. Below you can find the stocks with an unusual volume in today's session.
13 days ago - ChartmillThe trading volume of these stocks is deviating from the norm in today's session.Discover the stocks with unexpected trading volume in today's session on the US markets.
14 days ago - ChartmillCurious about what's happening in today's session? Check out the latest stock movements and price changes.Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
14 days ago - ChartmillTraders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
15 days ago - Can-Fite BioPharma Ltd.8 Years Survival with Complete Cure for a Patient with Advanced Liver Cancer Being Treated with Can-Fite’s Namodenoson DrugRAMAT GAN, Israel, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a...
a month ago - ACCESSWIRE60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVCANF Twits
Here you can normally see the latest stock twits on CANF, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
